Viewing Study NCT01168232


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2026-01-28 @ 9:41 AM
Study NCT ID: NCT01168232
Status: COMPLETED
Last Update Posted: 2019-08-08
First Post: 2010-07-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Uterine Corpus Sarcoma View
None Uterine Carcinosarcoma View
Keywords: